Biotechnology Annual Review PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Biotechnology Annual Review PDF full book. Access full book title Biotechnology Annual Review by M. Raafat El-Gewely. Download full books in PDF and EPUB format.
Author: M. Raafat El-Gewely
Publisher: Elsevier
ISBN: 0080553680
Category : Science
Languages : en
Pages : 379
Get Book Here
Book Description
Biotechnology is a diverse, complex and rapidly evolving field. Students and experienced researchers alike face the challenges of staying on top of developments in their field of specialty and maintaining a broader overview of the field as a whole. Volumes containing competent reviews on a diverse range of topics in the field fulfill the dual role of broadening and updating biotechnologists' knowledge. The current volume is an excellent example of such a book. The topics covered range from classical issues in biotechnology - such as, recent advances in all-protein chromophore technology- to topics that are focused on sequencing and recombinant vaccines. The information presented in this book will therefore will be of great value to both experienced biotechnologists and biotechnologists in training.* Includes over 200 figures with more than 60 tables* Discusses valuable information on pharming & transgenic plants * Provides detailed information on the production of plasmid DNA for pharmaceutical use
Author: M. Raafat El-Gewely
Publisher: Elsevier
ISBN: 0080553680
Category : Science
Languages : en
Pages : 379
Get Book Here
Book Description
Biotechnology is a diverse, complex and rapidly evolving field. Students and experienced researchers alike face the challenges of staying on top of developments in their field of specialty and maintaining a broader overview of the field as a whole. Volumes containing competent reviews on a diverse range of topics in the field fulfill the dual role of broadening and updating biotechnologists' knowledge. The current volume is an excellent example of such a book. The topics covered range from classical issues in biotechnology - such as, recent advances in all-protein chromophore technology- to topics that are focused on sequencing and recombinant vaccines. The information presented in this book will therefore will be of great value to both experienced biotechnologists and biotechnologists in training.* Includes over 200 figures with more than 60 tables* Discusses valuable information on pharming & transgenic plants * Provides detailed information on the production of plasmid DNA for pharmaceutical use
Author: M.R. El-Gewely
Publisher: Elsevier
ISBN: 008087732X
Category : Science
Languages : en
Pages : 497
Get Book Here
Book Description
The Biotechnology Annual Review covers the various developments in biotechnology in the form of comprehensive, illustrated and well referenced reviews. With the expansion of the field of biotechnology, coupled with the vast increase in the number of new journals reporting recent results in this field, the need for a publication that is continuously providing reviews is urgent. Hence, each volume of the Biotechnology Annual Review will have a number of reviews covering different aspects of biotechnology. Reviewed topics will include biotechnology applications in medicine, agriculture, marine biology, industry, bioremedation and the environment. Fundamental problems dealing with enhancing the technical knowledge encountering biotechnology utilization regardless of the field of application will be particularly emphasized. This series will help both students and teachers, researchers as well as administrators to remain knowledgeable on all relevant issues in biotechnology.Proposals for contributions and/or suggestions for topics for future volumes in this series should be sent to the Editor:professor M.R. El-GewelyDepartment of BiotechnologyUniversity of TromsløIMB, MH-ByggetN-9037 TromsøNorwayTel: (+47) 77 644000Fax: (+47) 77 645350
Author: Guozhong Cao
Publisher: World Scientific
ISBN: 9812705643
Category : Science
Languages : en
Pages : 650
Get Book Here
Book Description
The first volume in an exciting new series, Annual Review of Nano Research, this formidable collection of review articles sees renowned contributors from eight different countries tackle the most recent advances in nanofabrication, nanomaterials and nanostructures.The broad coverage of topics in nanotechnology and nanoscience also includes a special focus on the hot topic of biomedical applications of nanomaterials. The important names contributing to the volume include: M R Bockstaller (USA), L Duclaux (France), S Forster (Germany), W Fritzsche (Germany), L Jiang (China), C Lopez (Spain), W J Parak (Germany), B Samori (Italy), U S Schubert (The Netherlands), S Shinkai (Japan), A Stein (USA), S M Hou (China), and Y N Xia (USA).The volume serves both as a handy reference for experts active in the field and as an excellent introduction to scientists whose expertise lies elsewhere but who are interested in learning about this cutting-edge research area.
Author: Donald L. Drakeman
Publisher: Oxford University Press
ISBN: 0195084004
Category : Biotechnology industries
Languages : en
Pages : 241
Get Book Here
Book Description
"Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. How could a large collection of small companies, most with fewer than 50 employees, compete in one of the world's most breathtakingly expensive and highly regulated industries? This book shows how biotech companies have met the challenge by creating nearly 40% more of the most important treatments for unmet medical needs. Moreover, they have done so with much lower overall costs. The book focuses on both the companies themselves and the broader biotech ecosystem that supports them. Its portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies shows how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency. In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions. Looking to the future, it concludes that biomedical research will continue to be most effective in the hands of a large group of small companies as long as national healthcare policies allow the rest of the ecosystem to continue to thrive"--
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :
Get Book Here
Book Description
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309452058
Category : Science
Languages : en
Pages : 231
Get Book Here
Book Description
Between 1973 and 2016, the ways to manipulate DNA to endow new characteristics in an organism (that is, biotechnology) have advanced, enabling the development of products that were not previously possible. What will the likely future products of biotechnology be over the next 5â€"10 years? What scientific capabilities, tools, and/or expertise may be needed by the regulatory agencies to ensure they make efficient and sound evaluations of the likely future products of biotechnology? Preparing for Future Products of Biotechnology analyzes the future landscape of biotechnology products and seeks to inform forthcoming policy making. This report identifies potential new risks and frameworks for risk assessment and areas in which the risks or lack of risks relating to the products of biotechnology are well understood.
Author: Nicolas Rasmussen
Publisher: JHU Press
ISBN: 1421413418
Category : Medical
Languages : en
Pages : 260
Get Book Here
Book Description
The scientific scramble to discover the first generation of drugs created through genetic engineering. The biotech arena emerged in the 1970s and 1980s, when molecular biology, one of the fastest-moving areas of basic science in the twentieth century, met the business world. Gene Jockeys is a detailed study of the biotech projects that led to five of the first ten recombinant DNA drugs to be approved for medical use in the United States: human insulin, human growth hormone, alpha interferon, erythropoietin, and tissue plasminogen activator. Drawing on corporate documents obtained from patent litigation, as well as interviews with the ambitious biologists who called themselves gene jockeys, historian Nicolas Rasmussen chronicles the remarkable, and often secretive, work of the scientists who built a new domain between academia and the drug industry in the pursuit of intellectual rewards and big payouts. In contrast to some who critique the rise of biotechnology, Rasmussen contends that biotech was not a swindle, even if the public did pay a very high price for the development of what began as public scientific resources. Within the biotech enterprise, the work of corporate scientists went well beyond what biologists had already accomplished within universities, and it accelerated the medical use of the new drugs by several years. In his technically detailed and readable narrative, Rasmussen focuses on the visible and often heavy hands that construct and maintain the markets in public goods like science. He looks closely at how science follows money, and vice versa, as researchers respond to the pressures and potential rewards of commercially viable innovations. In biotechnology, many of those engaged in crafting markets for genetically engineered drugs were biologists themselves who were in fact trying to do science. This book captures that heady, fleeting moment when a biologist could expect to do great science through the private sector and be rewarded with both wealth and scientific acclaim.
Author: Scott Dessain
Publisher: Academic Press
ISBN: 0128092092
Category : Medical
Languages : en
Pages : 277
Get Book Here
Book Description
Preserving the Promise: Improving the Culture of Biotech Investment critically examines why most biotech startups fail, as they emerge from universities into an ecosystem that inhibits rather than encourages innovation. This "Valley of Death" squanders our public investments in medical research and with them, the promise of longer and healthier lives. The authors explicate the Translation Gap faced by early stage biotech companies, the result of problematic technology transfer and investment practices, and provide specific prescriptions for improving translation of important discoveries into safe and effective therapies. In Preserving the Promise, Dessain and Fishman build on their collective experience as company founders, healthcare investor (Fishman) and physician/scientist (Dessain). The book offers a forward-looking, critical analysis of "conventional wisdom" that encumbers commercialization practices. It exposes the self-defeating habits of drug development in the Valley of Death, that waste money and extinguish innovative technologies through distorted financial incentives. - Explains why translation of biotech discovery into medicine succeeds so infrequently that it's been dubbed the Valley of Death - Uncovers specific decision-making strategies that more effectively align incentives, improving clinical and financial outcomes for investors, inventor/entrepreneurs, and patients - Examines the critical, early stages of commercialization, where technology transfer offices and Angels act as gatekeepers to development, and where tension between short-term financial and long-term clinical aspirations sinks important technologies - Deconstructs the forces driving biotech, recasts them in a proven conceptual framework, and offers practical guidance for making the system better
Author: Arie Altman
Publisher: Academic Press
ISBN: 0123814669
Category : Business & Economics
Languages : en
Pages : 625
Get Book Here
Book Description
As the oldest and largest human intervention in nature, the science of agriculture is one of the most intensely studied practices. From manipulation of plant gene structure to the use of plants for bioenergy, biotechnology interventions in plant and agricultural science have been rapidly developing over the past ten years with immense forward leaps on an annual basis. This book begins by laying the foundations for plant biotechnology by outlining the biological aspects including gene structure and expression, and the basic procedures in plant biotechnology of genomics, metabolomics, transcriptomics and proteomics. It then focuses on a discussion of the impacts of biotechnology on plant breeding technologies and germplasm sustainability. The role of biotechnology in the improvement of agricultural traits, production of industrial products and pharmaceuticals as well as biomaterials and biomass provide a historical perspective and a look to the future. Sections addressing intellectual property rights and sociological and food safety issues round out the holistic discussion of this important topic. Includes specific emphasis on the inter-relationships between basic plant biotechnologies and applied agricultural applications, and the way they contribute to each other Provides an updated review of the major plant biotechnology procedures and techniques, their impact on novel agricultural development and crop plant improvement Takes a broad view of the topic with discussions of practices in many countries
Author: Michael Wink
Publisher: Taylor & Francis
ISBN: 9781841270081
Category : Science
Languages : en
Pages : 384
Get Book Here
Book Description
"The book is designed for use by advanced students, researchers and professionals in plant biochemistry, physiology, molecular biology, genetics, pharmacology, medicine, pharmacy and agriculture working in the academic and industrial sectors, including the pesticide and pharmaceutical industries."--Jacket.
